Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anticonvulsants | 2 | 2021 | 380 | 0.970 |
Why?
|
| Drug Resistant Epilepsy | 3 | 2024 | 208 | 0.950 |
Why?
|
| Basilar Artery | 9 | 2012 | 24 | 0.810 |
Why?
|
| Diet, Gluten-Free | 1 | 2021 | 4 | 0.750 |
Why?
|
| Epileptic Syndromes | 1 | 2021 | 30 | 0.720 |
Why?
|
| Celiac Disease | 1 | 2021 | 68 | 0.690 |
Why?
|
| Subarachnoid Hemorrhage | 6 | 2012 | 74 | 0.610 |
Why?
|
| Vasoconstriction | 5 | 2011 | 102 | 0.520 |
Why?
|
| Nitrobenzenes | 1 | 2014 | 16 | 0.480 |
Why?
|
| Diazepam | 1 | 2014 | 21 | 0.470 |
Why?
|
| Arginine Vasopressin | 2 | 2005 | 28 | 0.470 |
Why?
|
| Epilepsy | 4 | 2023 | 872 | 0.450 |
Why?
|
| Neuroprotective Agents | 1 | 2014 | 157 | 0.420 |
Why?
|
| Status Epilepticus | 1 | 2014 | 144 | 0.410 |
Why?
|
| Sulfonamides | 1 | 2014 | 261 | 0.410 |
Why?
|
| Vasoconstrictor Agents | 3 | 2011 | 136 | 0.380 |
Why?
|
| Nicotinic Agonists | 4 | 2012 | 45 | 0.360 |
Why?
|
| Muscle, Smooth, Vascular | 5 | 2012 | 237 | 0.340 |
Why?
|
| Nicotine | 4 | 2012 | 143 | 0.330 |
Why?
|
| Hippocampus | 1 | 2014 | 830 | 0.310 |
Why?
|
| Vasospasm, Intracranial | 2 | 2005 | 18 | 0.290 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2014 | 1228 | 0.290 |
Why?
|
| Leukotriene B4 | 2 | 2012 | 7 | 0.280 |
Why?
|
| Leukotriene C4 | 1 | 2005 | 4 | 0.260 |
Why?
|
| Leukotriene D4 | 1 | 2005 | 6 | 0.260 |
Why?
|
| Psychosurgery | 1 | 2023 | 27 | 0.210 |
Why?
|
| Tuberous Sclerosis | 1 | 2023 | 121 | 0.190 |
Why?
|
| Hashimoto Disease | 1 | 2021 | 21 | 0.190 |
Why?
|
| Arachidonic Acid | 4 | 2011 | 79 | 0.190 |
Why?
|
| Vitamin B 6 | 1 | 2021 | 10 | 0.190 |
Why?
|
| Vitamin B 6 Deficiency | 1 | 2021 | 6 | 0.190 |
Why?
|
| Rats | 11 | 2012 | 3687 | 0.180 |
Why?
|
| Encephalitis | 1 | 2021 | 109 | 0.180 |
Why?
|
| Disease Models, Animal | 3 | 2014 | 4355 | 0.170 |
Why?
|
| Endothelium, Vascular | 5 | 2007 | 515 | 0.170 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 280 | 0.160 |
Why?
|
| Neurology | 1 | 2020 | 108 | 0.160 |
Why?
|
| Muscle Contraction | 4 | 2012 | 186 | 0.150 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 2 | 2014 | 60 | 0.130 |
Why?
|
| Proteins | 1 | 2021 | 1044 | 0.120 |
Why?
|
| Pilocarpine | 1 | 2014 | 12 | 0.120 |
Why?
|
| Lithium Compounds | 1 | 2014 | 14 | 0.120 |
Why?
|
| Telemedicine | 1 | 2020 | 438 | 0.120 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2005 | 87 | 0.120 |
Why?
|
| Norepinephrine | 2 | 2005 | 173 | 0.110 |
Why?
|
| Cyclooxygenase 2 | 1 | 2014 | 159 | 0.110 |
Why?
|
| Electrodes, Implanted | 1 | 2014 | 168 | 0.110 |
Why?
|
| Brain Neoplasms | 1 | 2023 | 1244 | 0.110 |
Why?
|
| In Vitro Techniques | 4 | 2012 | 969 | 0.110 |
Why?
|
| Video Recording | 1 | 2014 | 183 | 0.110 |
Why?
|
| Child | 6 | 2024 | 24526 | 0.110 |
Why?
|
| Receptors, Eicosanoid | 1 | 2012 | 1 | 0.100 |
Why?
|
| Lipoxygenase Inhibitors | 3 | 2007 | 7 | 0.100 |
Why?
|
| Retrospective Studies | 4 | 2024 | 16233 | 0.100 |
Why?
|
| Coronary Vessels | 3 | 2005 | 537 | 0.100 |
Why?
|
| KATP Channels | 1 | 2011 | 6 | 0.100 |
Why?
|
| Calcium Channels, L-Type | 1 | 2011 | 53 | 0.090 |
Why?
|
| Child, Preschool | 3 | 2023 | 14085 | 0.090 |
Why?
|
| Pediatrics | 1 | 2020 | 1163 | 0.090 |
Why?
|
| Animals | 12 | 2014 | 34145 | 0.090 |
Why?
|
| Drug Therapy, Combination | 1 | 2014 | 1154 | 0.090 |
Why?
|
| Leukotriene Antagonists | 2 | 2012 | 17 | 0.090 |
Why?
|
| Receptors, Nicotinic | 1 | 2011 | 155 | 0.090 |
Why?
|
| Electroencephalography | 1 | 2014 | 868 | 0.080 |
Why?
|
| Adolescent | 3 | 2024 | 19358 | 0.080 |
Why?
|
| Male | 8 | 2024 | 61028 | 0.080 |
Why?
|
| Female | 8 | 2024 | 66305 | 0.080 |
Why?
|
| Seizures | 2 | 2023 | 878 | 0.070 |
Why?
|
| Hydroxyl Radical | 1 | 2006 | 9 | 0.070 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 2005 | 2 | 0.060 |
Why?
|
| Receptors, Leukotriene | 1 | 2005 | 6 | 0.060 |
Why?
|
| Benzopyrans | 1 | 2005 | 19 | 0.060 |
Why?
|
| Propionates | 1 | 2005 | 30 | 0.060 |
Why?
|
| Carboxylic Acids | 1 | 2005 | 24 | 0.060 |
Why?
|
| Infant | 1 | 2021 | 12479 | 0.060 |
Why?
|
| Tetrazoles | 1 | 2005 | 63 | 0.060 |
Why?
|
| Vasopressins | 1 | 2005 | 43 | 0.060 |
Why?
|
| Quinolines | 1 | 2005 | 96 | 0.060 |
Why?
|
| Oxytocin | 1 | 2005 | 68 | 0.060 |
Why?
|
| Pyrans | 1 | 2004 | 7 | 0.060 |
Why?
|
| Thalamic Nuclei | 1 | 2024 | 16 | 0.060 |
Why?
|
| Neurons | 1 | 2014 | 1965 | 0.060 |
Why?
|
| Pyrrolidines | 1 | 2004 | 36 | 0.060 |
Why?
|
| Endothelins | 1 | 2003 | 8 | 0.060 |
Why?
|
| Quinolones | 1 | 2004 | 53 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2024 | 12287 | 0.050 |
Why?
|
| Humans | 7 | 2024 | 124404 | 0.050 |
Why?
|
| Electric Stimulation Therapy | 1 | 2024 | 103 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2003 | 228 | 0.050 |
Why?
|
| Indoles | 1 | 2004 | 182 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2011 | 1688 | 0.050 |
Why?
|
| Neurologists | 1 | 2021 | 17 | 0.050 |
Why?
|
| Cyclooxygenase Inhibitors | 3 | 2007 | 63 | 0.050 |
Why?
|
| Pyridoxine | 1 | 2021 | 14 | 0.050 |
Why?
|
| Vitamin B Complex | 1 | 2021 | 41 | 0.040 |
Why?
|
| Young Adult | 2 | 2024 | 8979 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2011 | 4535 | 0.040 |
Why?
|
| Deep Brain Stimulation | 1 | 2024 | 410 | 0.040 |
Why?
|
| Cognition | 1 | 2021 | 737 | 0.030 |
Why?
|
| Saponins | 2 | 2007 | 22 | 0.030 |
Why?
|
| Thromboxane A2 | 2 | 2005 | 19 | 0.030 |
Why?
|
| Quality of Life | 1 | 2024 | 1954 | 0.030 |
Why?
|
| Rats, Wistar | 2 | 2005 | 360 | 0.030 |
Why?
|
| Receptors, Thromboxane A2, Prostaglandin H2 | 1 | 2012 | 11 | 0.030 |
Why?
|
| Nicotinic Antagonists | 1 | 2011 | 9 | 0.020 |
Why?
|
| Ganglionic Blockers | 1 | 2011 | 13 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2011 | 113 | 0.020 |
Why?
|
| Phospholipase A2 Inhibitors | 1 | 2007 | 3 | 0.020 |
Why?
|
| Type C Phospholipases | 1 | 2007 | 27 | 0.020 |
Why?
|
| Antidiuretic Hormone Receptor Antagonists | 1 | 2005 | 4 | 0.020 |
Why?
|
| Receptors, Vasopressin | 1 | 2005 | 11 | 0.020 |
Why?
|
| Spiro Compounds | 1 | 2005 | 13 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 2005 | 53 | 0.020 |
Why?
|
| Time Factors | 2 | 2006 | 6273 | 0.020 |
Why?
|
| Morpholines | 1 | 2005 | 55 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2007 | 578 | 0.010 |
Why?
|
| Flurbiprofen | 1 | 2003 | 5 | 0.010 |
Why?
|
| Leukotrienes | 1 | 2003 | 7 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2003 | 59 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 2003 | 49 | 0.010 |
Why?
|
| Cyclooxygenase 1 | 1 | 2003 | 40 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2003 | 232 | 0.010 |
Why?
|
| Rabbits | 1 | 2003 | 711 | 0.010 |
Why?
|
| Adult | 1 | 2023 | 29397 | 0.010 |
Why?
|
| Dogs | 1 | 2003 | 767 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2003 | 492 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2003 | 1529 | 0.010 |
Why?
|